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Research on hepatotoxicity has been intensified in recent years. This can be partly explained 
by large projects such as the German project Virtual Liver with more than 60 partners and the 
EU project NoTox where hepatocyte in vitro systems are applied and optimized. Hepatocyte 
cultures are well accepted in vitro systems in both pharmacology and toxicology (Hengstler et 
al., 2009a, b; Gebhardt et al., 2003; Hewitt et al., 2007; Godoy et al., 2010a, b; Meyer et al., 
2011). However, following isolation from the liver and attachment to the matrix of a culture 
dish, primary hepatocytes undergo major alterations, often referred to as dedifferentiation 
(Godoy et al., 2009; Zellmer et al., 2010). In contradiction to previous concepts, hepatocyte 
dedifferentiation is not a passive process during which some function are lost but represents 
an active response of the hepatocytes to the novel environment. This involves focal adhesion 
kinase mediated activation of PI3k/Akt and Raf/Mek/Erk signalling. Further progress in the 
field of hepatotoxicity will depend on whether it will become possible to optimize culture 
conditions, so that cultivated hepatocytes better reflect the in vivo situation. It is therefore un-
derstandable that several of the recent publications have used hepatocytes in vitro, either to 
opitimize techniques, such as hypothermic preservation (Ostrowska et al., 2009) or to under-
stand mechanisms of toxicity (e.g., Nakagawa et al., 2009; Arafa, 2009). A second cutting-
edge topic is  alcohol induced fatty liver which is addressed in two comprehensive articles 
(Zeng and Xie, 2009; Cederbaum et al., 2009) giving an overview over the key mechanisms, 
namely changes of the redox condition, transportation of lipids, altered fatty acid oxidation 
and the enhancement of lipogenesis. 
 
 
Table 1: Recent studies on hepatotoxicity 
 
Key message Reference 
 
Benzylpenicillin (BPCN) is an efficient antidote against amanitins in 
human hepatocytes. 
Magdalan et al., 2009 
Toxotrienol caused nodular hepatocellular hyperplasia (NHH) in a 
104-week carcinogenicity study in rats. However NHH did not be-
come neoplastic. 
Tasaki et al., 2009 
 
Alcohol induced fatty liver is a frequent health problem without effec-
tive therapy. This review addresses relevant mechanisms, including 
changes of the redox condition, transportation impairment of lipids, 
compromised fatty acid oxidation and the enhancement of lipogenesis 
with a focus on PPAR α and SREBP-1.  
Zeng and Xie, 2009 
Adequate animal models to predict idiosyncratic drug induced liver 
injury (DILI) represent a cutting-edge topic in toxicology. This study 
shows that aodiaquine induces hepatotoxicity in mice only after de-
pletion of glutathione. 
Shimizu et al., 2009 
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Table 1 (cont.): Recent studies on hepatotoxicity 
 
Key message Reference 
 
The perfluorinated compounds PFOA and PFOS are widely distrib-
uted in the environment. The current study addresses possible inter-
actions between both compounds in a human hepatoma cell line. 
However, only a summation effect was observed. 
Hu and Hu, 2009  
Trichloroethylene is known to cause hepatocellular cancer in mice. 
Microarray analysis after oral administration of trichloroethylene re-
vealed inhibition of the TGF-beta and activation of the MAPK signal-
ling pathways. 
Sano et al., 2009 
This review focusses on key mechanisms of alcohol-induced liver 
injury: production of reactive oxygen species, depletion of antioxi-
dants and induction of CYP2E1. 
Cederbaum et al., 2009; 
Hengstler et al., 2009a 
(editorial)  
To study which of several hypothermic preservation media lead to 
optimal results, primary human hepatocytes were analyzed after stor-
age at 4 °C for 24-72 h. The best results were obtained with Hy-
poThermosol-FRS. 
Ostrowska et al., 2009 
A novel rapid and easy to handle thermoluminescence assay has 
been established to quantify oxidative stress in primary hepatocytes. 
Schumann et al., 2009 
This study presents the toxicokinetics of arsenic species in the liver of 
mice. 
Juárez-Reyes et al., 2009 
This short editorial summarizes some current technical limitations of 
hepatocyte in vitro systems. 
Hengstler et al., 2009b 
Alpha-tocopherol ameliorates CCL4 induced liver necrosis and re-
stores hepatic vitamin C concentration. 
Iida et al., 2009 
Tert-butyl hydroperoxide drecreases intracellular glutathione and mi-
tochondrial membrane potential in rat hepatocytes. 
Cervinková et al., 2009 
Alpha-amanitin shows a biphasic course of toxicity in cultivated dog 
hepatocytes with inhibition of protein and urea synthesis, marginaliza-
tion and condensation of nuclear chromatin in a first phase, and ne-
crosis and apoptosis in a second phase. 
Magdalan et al., 2009 
Using a rat hepatocarcinogenesis model the anthelmintic oxfendazole 
shows tumor promoting activity by generation of reactive oxygen spe-
cies. 
Dewa et al., 2009 
Quinacrine inhibits CYP2E1 in rat livers and protects against genotox-
icity by the CYP2E1 activated tobacco specific nitrosamine NNK. 
Karamanakos et al., 2009 
4-Tert-octylphenol causes liver toxicity in rats. Barlas and Aydoğan, 2009 
Carnitine deficiency increases susceptibility to paracetamol induced 
hepatotoxicity. 
Arafa, 2009 
The amphetamine-derived designer drugs MDMA and MBDB induce 
mitochondrial depolarization and cause DNA damage in rat hepato-
cytes. 
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